Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia.
Leuk Lymphoma
; 61(10): 2399-2408, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32558607
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Waldenstrom Macroglobulinemia
/
Proteasome Inhibitors
Limits:
Animals
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos